Atomy HemoHIM recorded its biggest sales in the past year

– Report datetime 2023.07.31 1:54 p.m.

9 consecutive years of peak performance The leading exporter of health functional foods in Korea

Atomy HemoHIM recorded its largest annual sales of KRW 185.1 billion over the past year.
HemoHIM crossed the threshold of 100 billion KRW in domestic annual sales in 2014 with 106.7 billion KRW. Since then, the company has recorded annual revenue of over KRW 100 billion for nine consecutive years and is on the verge of reaching the KRW 200 billion mark. Cumulative global sales exceeded 2 trillion KRW in 2022.

According to the domestic network marketing company information released by the Fair Trade Commission on July 26, Atomy HemoHIM has been the best-selling product in the network marketing industry for 9 consecutive years from 2014 to 2022.
Atomy HemoHIM is Korea’s first network marketing product. Individually recognized functional health food, developed with the main patented ingredients “HemoHIM Angelica Gigas Extract Mixture”, developed by the Korea Atomic Energy Research Institute. According to the “2021 Food Production Performance, etc. » released by the Ministry of Food and Drug Safety in 2022, “HemoHIM Angelica Gigas Extract Blend” exported $60.48 million (approximately KRW 70 billion based on the average exchange rate of 2021 ), surpassing red ginseng, which exported $48.32 million (approximately KRW 55.3 billion). billion), making it the highest export value among domestic health functional foods.

HemoHIM sales trend
Units: 100 million KRW